Alpelisib

ATC L01EM03 · 10 markets · 38 records

Alpelisib 10 markets · 38 records Forms

US 11 records · 5 strengths

  • 200 mgtabletPIQRAYManufacturer: Novartis Pharma Stein AG also in GB·CA·AU +3
  • 50 mgtabletVIJOICEManufacturer: Novartis Pharma Stein AG also in GB·CA·AU +3
  • 150 mgtabletPIQRAYManufacturer: Novartis Pharma Stein AG also in GB·CA·AU +3
  • 125 mgtabletVIJOICEManufacturer: Novartis Pharma Stein AG
  • 50 mgpowderVIJOICE

GB 4 records · 3 strengths

CA 4 records · 3 strengths

AU 4 records · 4 strengths

  • 200 mgtabletPIQRAY alpelisib 200 mg daily dose blister (200 mg tablet)PIQRAY alpelisib 250 mg daily dose blister (200+50 mg tablet) composite pack also in US·GB·CA +3 unknown
  • 50 mgtabletPIQRAY alpelisib 250 mg daily dose blister (200+50 mg tablet) composite pack also in US·GB·CA +3 unknown
  • 150 mgtabletPIQRAY alpelisib 200 mg daily dose blister (200 mg tablet) also in US·GB·CA +3 unknown

Records without a stated strength · 1 PIQRAY

SG 3 records · 3 strengths

ES 3 records · 3 strengths

TW 3 records · 3 strengths

  • 200 mgtabletPIQRAY愛克利200毫克膜衣錠 also in US·GB·CA +3
  • 50 mgtabletPIQRAY愛克利50毫克膜衣錠 also in US·GB·CA +3
  • 150 mgtabletPIQRAY愛克利150毫克膜衣錠 also in US·GB·CA +3

HK 3 records · 1 strengths

    Records without a stated strength · 1 PIQRAY

    EU 2 records · 1 strengths

    EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

      Records without a stated strength · 1 PIQRAY、VIJOICE

      MX 1 records · 1 strengths

        Records without a stated strength · 1 PIQRAY

        Side-by-side table

        The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

        Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.